Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 1st February Professor Daniel Freeman (Psychiatry) and Professor David M Clark (Experimental Psychiatry) were presented with NIHR’s i4i (Invention for Innovation Award) Mental Health Challenge Award by Health Minister Lord O’Shaughnessy.  The record award (£3.9m) was received on behalf of a large multidisciplinary team led by Professor Freeman that will build on their early experimental demonstration (http://bjp.rcpsych.org/content/early/2016/04/07/bjp.bp.115.176438) that encountering feared situations in a virtual environment can substantially reduce the fears of people with paranoid psychosis and help them re-engage in everyday life. 

In the new work, the team will refine the virtual reality treatment to ensure it is appealing and easy to use. They will then test it in a large scale randomised controlled trial. If that trial confirms the clinical and cost-effectiveness of the treatment, the final phase of the work will involve careful implementation within the NHS. To achieve these goals, researchers from 5 different universities and mental health trusts are working closely together with a design team from the Royal College of Art, with an Oxford spinout company (Nowican)  and with service users led by the McPin Foundation. For more details of the work, see Daniel Freeman’s recent blog:  https://www.nihr.ac.uk/blogs/virtual-benefits-for-the-real-world/7844

Similar stories

New funding awarded to study persistent pain in inflammatory arthritis

The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.

NIHR Awards Oxford Health Clinical Research Facility £4 million Over Next Five Years

The Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly £161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.

Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to the Nuffield Department of Clinical Neurosciences to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.